APOA1 and systemic lupus erythematosus: Development of damage (due to disease activity or therapy) is a powerful risk factor for mortality [29] in SLE but we found no association between IgG anti-apoA-1 level and SLICC-DI score over a 10-year follow-up period in over 200 patients (Table 3).